Kihealth Announces Launch of Beta Intercept™, Advancing Real-Time Detection of Diabetes
Next-generation cfDNA assay built on the Kihealth InterceptIQ™ platform expands the potential for earlier detection, dynamic disease monitoring, and precision therapeutic development in diabetes and metabolic disease
June 5, 2026